Beta Glucan Assay in Patients Receiving Voriconazole Prophylaxis

Completed · Phase 3

Conditions studied: Leukemia, Fungal Infection

In brief

Objectives: To investigate the relationship between the administration of intravenous (IV) and oral voriconazole (vori) and the occurrence of false positive (1,3) beta-d- glucan (BG) relative to the standard assessment criteria used to diagnose invasive fungal infection in patients with hematologic malignancies.

Key facts

Study ID
NCT00904995
Run by
M.D. Anderson Cancer Center
People needed
23
Starts
2009-05-01
Expected to finish
2010-07-01
Last updated by the study team
2012-08-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.